Targeting the TGFβ pathway for cancer therapy
Inserm · Assistance Publique – Hôpitaux de Paris · +4 more institutions
Abstract
The TGFβ signaling pathway has pleiotropic functions regulating cell growth, differentiation, apoptosis, motility and invasion, extracellular matrix production, angiogenesis, and immune response. TGFβ signaling deregulation is frequent in tumors and has crucial roles in tumor initiation, development and metastasis. TGFβ signaling inhibition is an emerging strategy for cancer therapy. The role of the TGFβ pathway as a tumor-promoter or suppressor at the cancer cell level is still a matter of debate, due to its differential effects at the early and late stages of carcinogenesis. In contrast, at the microenvironment level, the TGFβ pathway contributes to generate a favorable microenvironment for tumor growth and…
Citation impact
- FWCI
- 14.94
- Percentile
- 100%
- References
- 96
Authors
7- CNCindy Neuzillet
Inserm, Assistance Publique – Hôpitaux de Paris, Hôpital Beaujon, Université Paris Cité
- ATAnnemilaï Tijeras‐Raballand
Fidal
- RCRomain Cohen
Fidal
- JCJérôme Cros
Université Paris Cité, Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris
- SFSandrine Faivre
Université Paris Cité, Inserm, Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris
Topics & keywords
- Tumor microenvironment
- Cancer research
- Carcinogenesis
- Angiogenesis
- Metastasis
- Signal transduction
- Cancer
- Biology
- Good health and well-being